Basic Pharma

Basic Pharma

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Basic Pharma is a full-service CDMO headquartered in Amsterdam, founded in 2005, specializing in small molecule and drug delivery services. It operates a GMP-certified facility offering manufacturing, laboratory, and consultancy services tailored to client needs from early clinical phases through commercialization. The company is leveraging its regulatory and production expertise to expand into the biologics space, positioning itself as a versatile partner for pharmaceutical and biotech companies.

Drug DeliverySmall Molecules

Technology Platform

GMP-compliant manufacturing facility for small molecule dosage forms (liquids, semi-solids, delivery systems) and analytical testing, with expansion into biologicals manufacturing.

Opportunities

The expansion into biologics CDMO services taps into a high-growth market segment.
Additionally, ongoing demand for complex drug delivery systems and generic medicines in Europe provides stable service opportunities.

Risk Factors

Intense competition from larger global CDMOs and the significant execution risk associated with expanding into capital-intensive biologics manufacturing.
The business is also perpetually exposed to regulatory compliance risks and client concentration dependencies.

Competitive Landscape

Basic Pharma competes in a fragmented but competitive European CDMO market against large multinational firms (e.g., Lonza, Catalent) and numerous smaller, specialized providers. Its differentiation is based on full-service support, quality focus, and flexibility for small-to-mid-sized clients, though it lacks the scale of its largest competitors.